<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="tbl2" position="float">
 <label>Table 2</label>
 <caption>
  <title>Surface-Modified Antiviral AgNPs and Possible Mechanisms of Action</title>
 </caption>
 <table frame="hsides" rules="groups" border="0">
  <colgroup>
   <col align="left"/>
   <col align="left"/>
   <col align="char" char="."/>
   <col align="left"/>
   <col align="left"/>
   <col align="left"/>
  </colgroup>
  <thead>
   <tr>
    <th style="border:none;" align="center">virus</th>
    <th style="border:none;" align="center">shape</th>
    <th style="border:none;" align="center" char=".">size (nm)</th>
    <th style="border:none;" align="center">coating</th>
    <th style="border:none;" align="center">mechanism of action</th>
    <th style="border:none;" align="center">ref</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td style="border:none;" align="left">HIV-1</td>
    <td style="border:none;" align="left">spherical</td>
    <td style="border:none;" align="char" char=".">1–10</td>
    <td style="border:none;" align="left">foamy carbon, PVP and BSA</td>
    <td style="border:none;" align="left">interaction with gp120</td>
    <td style="border:none;" align="left">(
     <xref ref-type="bibr" rid="ref11">11</xref>)
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">RSV</td>
    <td style="border:none;" align="left">spherical</td>
    <td style="border:none;" align="char" char=".">–</td>
    <td style="border:none;" align="left">PVP, BSA, and recombinant F protein (RF 412)</td>
    <td style="border:none;" align="left">interaction with the G-protein on the virus surface</td>
    <td style="border:none;" align="left">(
     <xref ref-type="bibr" rid="ref26">26</xref>)
    </td>
   </tr>
   <tr>
    <td rowspan="4" style="border:none;" align="left">H1N1 influenza virus</td>
    <td rowspan="4" style="border:none;" align="left">spherical</td>
    <td rowspan="4" style="border:none;" align="char" char=".">2–5</td>
    <td style="border:none;" align="left">Oseltamivir</td>
    <td rowspan="3" style="border:none;" align="left">inhibition of the activity of neuraminidase and hemagglutinin</td>
    <td style="border:none;" align="left">(
     <xref ref-type="bibr" rid="ref34">34</xref>)
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">Amantadine</td>
    <td style="border:none;" align="left">(
     <xref ref-type="bibr" rid="ref35">35</xref>)
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">Zanamivir</td>
    <td style="border:none;" align="left">(
     <xref ref-type="bibr" rid="ref36">36</xref>)
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">inhibition of accumulation of reactive oxygen species (ROS)</td>
    <td style="border:none;" align="left"> </td>
    <td style="border:none;" align="left"> </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">HAV, NoV and CoxB
     <sub>4</sub>
    </td>
    <td style="border:none;" align="left">spherical</td>
    <td style="border:none;" align="char" char=".">–</td>
    <td style="border:none;" align="left">polyphosphonium-oligochitosans</td>
    <td style="border:none;" align="left">preventing viral attachment and penetration</td>
    <td style="border:none;" align="left">(
     <xref ref-type="bibr" rid="ref29">29</xref>)
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">MPV</td>
    <td style="border:none;" align="left">spherical</td>
    <td style="border:none;" align="char" char=".">10–80</td>
    <td style="border:none;" align="left">polysaccharide</td>
    <td style="border:none;" align="left">blocking virus-host cell binding and penetration</td>
    <td style="border:none;" align="left">(
     <xref ref-type="bibr" rid="ref22">22</xref>)
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">TCRV</td>
    <td style="border:none;" align="left">spherical</td>
    <td style="border:none;" align="char" char=".">10</td>
    <td style="border:none;" align="left">polysaccharide</td>
    <td style="border:none;" align="left">inactivation of virus particles prior to entry</td>
    <td style="border:none;" align="left">(
     <xref ref-type="bibr" rid="ref23">23</xref>)
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">HSV-1</td>
    <td style="border:none;" align="left">spherical</td>
    <td style="border:none;" align="char" char=".">4</td>
    <td style="border:none;" align="left">mercaptoethanesulfonate</td>
    <td style="border:none;" align="left">competition for the binding of the virus to the cell</td>
    <td style="border:none;" align="left">(
     <xref ref-type="bibr" rid="ref30">30</xref>)
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">Enterovirus 71 (EV71)</td>
    <td style="border:none;" align="left">spherical</td>
    <td style="border:none;" align="char" char=".">2–5</td>
    <td style="border:none;" align="left">PEI and antiviral siRNA</td>
    <td style="border:none;" align="left">inhibition of the accumulation of ROS and activation of AKT and p53</td>
    <td style="border:none;" align="left">(
     <xref ref-type="bibr" rid="ref37">37</xref>)
    </td>
   </tr>
   <tr>
    <td style="border:none;" align="left">HSV-2</td>
    <td style="border:none;" align="left">spherical</td>
    <td style="border:none;" align="char" char=".">13, 33, 46</td>
    <td style="border:none;" align="left">tannic acid</td>
    <td style="border:none;" align="left">direct interaction and blocking of virus attachment, penetration and spread</td>
    <td style="border:none;" align="left">(
     <xref ref-type="bibr" rid="ref28">28</xref>)
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
